Universal Ibogaine Inc. (TSXV: IBO)
Health Care · Health Care Providers & Services · CA
CA$—
— today · — 1Y
Universal Ibogaine Inc. (TSXV: IBO) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.14M.
trading between 0.01 and 0.05.
Tweenvest scores Universal Ibogaine Inc. across four factors: quality 12/100, value 61/100. Its strongest factor is value.
IBO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.14M
- Revenue (TTM)
- $1.49M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 4.37
- 52-week high
- CA$0.05
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 312.86M
- Employees
- —
- Next earnings
- —
About Universal Ibogaine Inc.
Universal Ibogaine Inc. is a life sciences enterprise that focuses on creating, obtaining, and managing addiction treatment centers throughout Canada. The company is also actively involved in scheduled clinical trials, researching the efficacy of ibogaine as a treatment for addiction. Its operations are directed from its head office in Calgary, Canada.
- ISIN
- CA91360F1099
- Listed since
- Jun 22, 2017
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $357.92B | $397.86 | -0.23% |
| CVS Health CorporationNYSE: CVS | $120.36B | $93.17 | -1.00% |
| McKesson CorporationNYSE: MCK | $101.88B | $888.16 | +1.64% |
| HCA Healthcare, Inc.NYSE: HCA | $92.93B | $428.15 | -0.25% |
| Elevance Health, Inc.NYSE: ELV | $87.32B | $400.71 | -0.48% |
| The Cigna GroupNYSE: CI | $74.11B | $278.43 | -0.72% |
| Cencora, Inc.NYSE: COR | $61.78B | $324.24 | +0.15% |
| Cardinal Health, Inc.NYSE: CAH | $54.04B | $234.56 | +0.94% |
Figures last refreshed Aug 18, 2026.